抗リウマチ薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1837)
◆英語タイトル:Global Antirheumatics Pharmaceutical Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1837
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、抗リウマチ薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(非ステロイド性抗炎症薬、ステロイド性抗炎症薬、遅効性薬、免疫学的準備)、用途別市場規模(製薬業、病院&診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・抗リウマチ薬の市場動向
・企業の競争状況、市場シェア
・抗リウマチ薬の種類別市場規模(非ステロイド性抗炎症薬、ステロイド性抗炎症薬、遅効性薬、免疫学的準備)
・抗リウマチ薬の用途別市場規模(製薬業、病院&診療所、その他)
・抗リウマチ薬の北米市場規模2016-2027(アメリカ、カナダ)
・抗リウマチ薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・抗リウマチ薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・抗リウマチ薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・抗リウマチ薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AbbVie、Amgen、Pfizer、Roche Holding AG、Novartis International AG、Johnson & Johnson、Bristol-Myers Squibb、Merck、UCB S.A.、Eli Lilly and Company)
・結論
【レポートの概要】

Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.

Market Analysis and Insights: Global Antirheumatics Pharmaceutical Market
The global Antirheumatics Pharmaceutical market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antirheumatics Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antirheumatics Pharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antirheumatics Pharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antirheumatics Pharmaceutical market.

Global Antirheumatics Pharmaceutical Scope and Market Size
Antirheumatics Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antirheumatics Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation

Segment by Application
Pharmaceutical Industry
Hospital and Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Steroidal Anti-Inflammatory Drugs
1.2.4 Slow Acting Drug
1.2.5 Immunological Preparation
1.3 Market by Application
1.3.1 Global Antirheumatics Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antirheumatics Pharmaceutical Market Perspective (2016-2027)
2.2 Antirheumatics Pharmaceutical Growth Trends by Regions
2.2.1 Antirheumatics Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antirheumatics Pharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Antirheumatics Pharmaceutical Industry Dynamic
2.3.1 Antirheumatics Pharmaceutical Market Trends
2.3.2 Antirheumatics Pharmaceutical Market Drivers
2.3.3 Antirheumatics Pharmaceutical Market Challenges
2.3.4 Antirheumatics Pharmaceutical Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antirheumatics Pharmaceutical Players by Revenue
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
3.4 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.4.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2020
3.5 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.7 Date of Enter into Antirheumatics Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antirheumatics Pharmaceutical Breakdown Data by Type
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2022-2027)

5 Antirheumatics Pharmaceutical Breakdown Data by Application
5.1 Global Antirheumatics Pharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antirheumatics Pharmaceutical Market Size (2016-2027)
6.2 North America Antirheumatics Pharmaceutical Market Size by Type
6.2.1 North America Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
6.3 North America Antirheumatics Pharmaceutical Market Size by Application
6.3.1 North America Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
6.4 North America Antirheumatics Pharmaceutical Market Size by Country
6.4.1 North America Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antirheumatics Pharmaceutical Market Size (2016-2027)
7.2 Europe Antirheumatics Pharmaceutical Market Size by Type
7.2.1 Europe Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
7.3 Europe Antirheumatics Pharmaceutical Market Size by Application
7.3.1 Europe Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Country
7.4.1 Europe Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type
8.2.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application
8.3.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region
8.4.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antirheumatics Pharmaceutical Market Size (2016-2027)
9.2 Latin America Antirheumatics Pharmaceutical Market Size by Type
9.2.1 Latin America Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Antirheumatics Pharmaceutical Market Size by Application
9.3.1 Latin America Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Antirheumatics Pharmaceutical Market Size by Country
9.4.1 Latin America Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type
10.2.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application
10.3.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country
10.4.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
11.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Antirheumatics Pharmaceutical Introduction
11.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
11.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Details
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
11.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.4.5 Roche Holding AG Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Details
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
11.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.5.5 Novartis International AG Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
11.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
11.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Antirheumatics Pharmaceutical Introduction
11.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.8.5 Merck Recent Development
11.9 UCB S.A.
11.9.1 UCB S.A. Company Details
11.9.2 UCB S.A. Business Overview
11.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
11.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.9.5 UCB S.A. Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
11.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗リウマチ薬の世界市場規模・現状・予測2021年-2027年(Global Antirheumatics Pharmaceutical Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。